Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

NCT00215501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Capecitabine
DRUG: 5-Fluorouracil (5-FU)
DRUG: Irinotecan
DRUG: Cisplatin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]